The objective of the current study was to determine the effect of ractopamine supplementation on gut populations and fecal shedding of Salmonella in growing pigs. Sixteen crossbred pigs (avg. BW = 33 kg) were fed a grower ration with and without ractopamine (18 g/ton feed) for 38 days. Four days prior to termination of the study, all pigs were experimentally infected with Salmonella Typhimurium. Fecal samples were collected daily for quantification of the challenge strain and four days following inoculation, all pigs were euthanized and necropsied. Fecal shedding of Salmonella was decreased (P < 0.05) in pigs fed ractopamine. The number of Salmonella-positive tissue samples from the liver was decreased (P = 0.05) and the number of positive ileo-cecal lymph nodes tended (P = 0.13) to decrease in the ractopamine treatment. Results of this preliminary study indicate ractopamine may have the added benefit of reducing Salmonella populations in growing pigs.
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the objective of the current research: to determine the effect of ractopamine supplementation on gut populations and fecal shedding of Salmonella, an important gram negative bacterial pathogen, in swine.
Materials and Methods
Sixteen crossbred pigs (barrows and gilts; avg. BW = 33 kg) were purchased from the Texas Department of Criminal Justice and transported to our facilities at the Food and Feed Safety Research Unit in College Station, TX. Immediately upon arrival, piglets were weighed, ear-tagged, and randomly assigned to pens (8 pigs/pen) and treatment (sex equally distributed across treatments): Control (pig grower only) or Ractopamine (pig grower containing Paylean ® 9, to provide 18 g ractopamine/ton feed). Feed and water were provided for ad libitum consumption throughout the experimental period. Fourteen days after initiation of treatments, pigs were individually penned and fed their respective diets for an additional 24 days (38 total days on experimental diets). Two days following individual penning, fecal samples were collected from all pigs and plated on brilliant green agar containing novobiocin and naladixic acid (25 and 20 µg/mL, respectively; BGANN) to screen for the presence of antibiotic resistant wild-type Salmonella prior to experimental infection. On day 34, all pigs were experimentally infected with 5 mL of tryptic soy broth containing 4.5 x 10 7 CFU of a novobiocin and naladixic acid resistant Salmonella Typhimurium via oral gavage. Individual fecal samples were collected daily for quantification of the challenge strain as described below. Four days post-infection, all pigs were humanely euthanized and tissue and luminal contents collected from the ileum, cecum, colon and rectum. Tissue samples were also collected from the ileocecal lymph nodes, spleen, and liver for qualification of Salmonella. Body weights were recorded at the beginning and end of the study. Salmonella Culture Fecal samples and luminal contents (1 g) were serially diluted, plated on BGANN agar and incubated overnight (24 h, 37°C). Tissue samples were enriched in tetrathionate broth (24 h, 37°C) before plating on BGANN for qualitative determination of the challenge strain. Statistical Analyses Daily fecal shedding data were analyzed as repeated measures using the MIXED procedure of SAS (SAS Inst. Inc., Cary, NC). Chi-square analysis using the FREQ procedure of SAS, was used to determine influence of treatment on qualitative bacterial enumeration of tissue samples. Salmonella populations in luminal contents and BW were subjected to analysis of variance appropriate for a completely randomized design. Least square means were compared using Duncan's mean separation statement when significant (P<0.05) differences detected.
Results Prior to challenge with the experimental Salmonella strain, all fecal samples were negative for wild-type Salmonella capable of growth on BGANN. Fecal shedding of the challenge strain of Salmonella is presented by day (Figure 1 ), even though a treatment by day interaction was not observed (P>0.20). Salmonella shedding was higher in the control animals each day post-challenge, decreasing over time (P<0.01), with low levels of shedding detected only in control animals by the end of the experimental period. When examined across days, pigs fed ractopamine shed less (P<0.01) Salmonella than control animals over this four day period (Table 1) . Populations of Salmonella in the luminal contents of the ileum, cecum and rectum were not different (P>0.20) due to treatment, while counts in the colon contents were one log lower in the ractopamine treatment (P=0.18). The number of Salmonella-positive tissue samples from the liver was decreased (P=0.05) and the number of positive ileo-cecal lymph nodes tended (P=0.13) to decrease in the ractopamine treatment (Table 1) . Body weights were similar among treatments prior to initiation of experimental diets. Pigs fed ractopamine tended (P=0.13) to gain weight over 
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the 38 day feeding period (Table 1) . Feed intakes were similar among treatments (data not shown).
Discussion Results of the current research indicate that ractopamine supplementation to growing pigs may influence gut populations and fecal shedding of Salmonella Typhimurium and indicate further research is warranted. We hypothesized that ractopamine would produce responses in gram-negative bacteria similar to those reported for the catecholamines (Burton et al, 2002 Rahman et al, 2000 and increase Salmonella populations. Interestingly, all of the affects observed in the ractopamine treatment, although slight involved a reduction, not an increase as we expected, in Salmonella. Reasons for this are unknown but may involve changes in hormone concentrations, gut turnover, effect on smooth muscle contraction, or other unknown mechanisms. Previously, we fed ractopamine to feedlot cattle naturally-infected with E. coli O157:H7 and saw a decrease in the number of ractopamine supplemented cattle shedding this pathogen (Edrington et al, 2005) . Plasma catecholamines were not different among treatment groups and did not provide any explanation for the observed results. Due to the results in the cattle study coupled with the difficulty in handling and restraining pigs and the stress involved, we did not collect blood samples for catecholamine analysis in this preliminary study with swine. Future studies utilizing less stressful catheterization procedures may be employed to examine catecholamine concentrations while limiting as much as possible, the stress associated with blood collection. While the effects observed in the current study are modest, increasing the numbers of animals used and thereby the sensitivity and ability to detect differences, may yield more substantial effects of ractopamine supplementation on pathogen populations.
Conclusions
The effects of ractopamine on performance and carcass characteristics in finishing swine are well documented. The present work has exciting implications considering this compound, designed to be fed immediately prior to slaughter, may have the added benefit of reducing foodborne pathogens. Future work will examine the effects of ractopamine feeding in market hogs naturally colonized with Salmonella. 
